Q&A With Giovanni Ortenzi, Vice President Of Pharmaceutical Development And Chief Technical Officer, Adare Pharma Solutions

When Adare Pharma Solutions was acquired in September of 2020 by two private equity firms known for activating growth and innovation, the company sent a signal to organizations that depend on contract development and manufacturing services to bring their pharma solutions to the healthcare market: if you need a trusted partner, now more than ever, Adare is a winning choice.

We asked Giovanni Ortenzi, Vice President of Pharmaceutical Development and Chief Technical Officer, a 24-year veteran of Adare Pharma Solutions, to explain the company’s strategy for becoming a global leader in CDMO services. Before taking the reins as vice president in 2019, Ortenzi split his career evenly between quality and industrial operations, where he gained an appreciation for the entire cycle of developing and manufacturing new pharma products.

Here, Ortenzi describes how pharma companies can leverage Adare’s unique CDMO capabilities and proprietary technologies.